| HS Code | 455772 |
| Compound Name | tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate |
| Molecular Formula | C13H22O5 |
| Cas Number | 1642383-70-3 |
| Appearance | Colorless to pale yellow oil |
| Boiling Point | No data available |
| Melting Point | No data available |
| Density | No data available |
| Smiles | CC(C)(C)OC(=O)CC1COC(C)(O1)C=O |
| Inchi | InChI=1S/C13H22O5/c1-12(2,3)17-11(16)6-10-7-18-13(4,5)9(8-14)15-10/h8,10H,6-7H2,1-5H3/t10-,13-/m1/s1 |
| Stereochemistry | (4R,6S) |
| Functional Groups | Dioxane, formyl (aldehyde), ester (tert-butyl ester) |
| Solubility | No data available |
| Storage Conditions | Store at 2-8°C, protect from light and moisture |
As an accredited tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The product is supplied in a 5-gram amber glass bottle with a tamper-evident cap and detailed labeling for laboratory use. |
| Container Loading (20′ FCL) | 20′ FCL container loads approximately 7–10 metric tons of tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate, securely packed in drums. |
| Shipping | The chemical `tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate` is shipped in tightly sealed containers under cool, dry conditions. It should be protected from light, heat, and moisture during transit. Proper labeling and documentation complying with relevant chemical shipping regulations are provided to ensure safe and compliant transportation. |
| Storage | Store **tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate** in a tightly sealed container under an inert atmosphere (e.g., nitrogen or argon) in a cool, dry, and well-ventilated area. Protect from moisture, light, and heat. Keep away from strong acids, bases, and oxidizing agents. Refrigeration (2–8 °C) is recommended for prolonged storage to maintain stability. |
| Shelf Life | Shelf life: Store at 2–8°C, protected from moisture and light; stable for at least 12 months under recommended conditions. |
As an advanced intermediate with well-defined stereochemistry and a protected functional group profile, tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate enables reliable synthesis of complex molecules in highly regulated industries. Our pure, quality-consistent supply supports diverse formulating needs and ensures tight control in pharma, agrochem, and specialty chemical applications.
Pharmaceutical manufacturers engage tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate as a protected intermediate in stereocontrolled syntheses of carbohydrate-based drug molecules. The stable formyl and dioxane functionalities allow selective deprotection steps in sequential API assembly. Acting as a masked building block, the compound provides necessary stability during robust reaction sequences, which is crucial for maintaining chiral purity across multi-step GMP production runs for cardiovascular, antiviral, and oncological APIs.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Specialty pharmaceutical developers utilize this chiral dioxane derivative for prodrug syntheses, where the masked formyl group delivers controlled reactivity in coupling reactions. The tert-butyl ester provides temporary protection, allowing selective transformations before final hydrolysis. This strategy supports the manufacture of prodrugs with enhanced solubility, targeting, and site-specific release, critical in improving pharmacokinetics for next-generation oral and injectable formulations.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Producers of oligosaccharides and glycomimetics select this compound as a stable, stereoselective glycosyl donor precursor. The 1,3-dioxane scaffold and protected functional groups guide selective glycosidic linkage formation, indispensable for the precise assembly of oligosaccharide chains in both solution-phase and solid-phase synthesis. Process engineers optimize the addition to match chain length targets and minimize undesired isomers in regulated environments.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Innovative agrochemical manufacturers rely on tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate for constructing chiral skeletons within selective herbicide candidates. Its rigid dioxane ring and chiral centers facilitate the synthesis of biologically active herbicidal intermediates that display high selectivity for target plant species. The protected aldehyde enables fine-tuned stepwise transformations, key for engineering compounds with improved safety and environmental compatibility.
Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
Competitive tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8618005193850 or mail to sales8@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8618005193850
Email: sales8@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
As a producer deeply rooted in fine chemical synthesis, our view of tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate draws on hundreds of hands-on batch preparations and years of on-site work. Each lot taught us more about the crucial role reliable building blocks play in pharmaceutical and advanced material development. From our own reactors to storage and QC, this compound has grown into a reliable resource for process chemists and research partners.
In practical terms, this tert-butyl dioxane derivative brings together several strengths. The dioxane ring—rigid, but not brittle—provides a backbone that doesn't buckle under mild heating or rotary evaporation. Dimethyl substitutions keep it protected from unwanted side attacks, making a big difference during scale-up or multistep syntheses. The formyl group comes exposed, but with enough surrounding structure that side reactions slow down, compared to simpler aldehydes.
The tert-butyl ester, instead of a methyl or ethyl group, offers two key benefits on the production line. It stands up to most saponification conditions used to remove protective groups later in synthesis, but cleaves efficiently in mild acid. Our technical staff have seen how this streamlines post-reaction work-ups; less time tweaking conditions, more time monitoring yield and purity.
Every reaction tells a story, and over repeated campaigns we fine-tuned both analytical targets and process parameters. For tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate, we track specific rotation, NMR signal sharpness, and residual solvent profiles. An untrusted batch may show barely-there extra peaks on the NMR—often the first sign of ring-openers or trace impurities from rushed scale-up. Our team does not skip these red flags.
Standard prep runs base themselves on chromatographic purity above 99%, low moisture content, and uniform color after crystallization. We won’t let minor specks or discoloration pass, since they point to unwanted byproducts. This approach came from both customer feedback and experience with failed pilot campaigns. Careful housekeeping at each recrystallization and drying step pays off: no end-user wants extra TLC just to bring a starting material up to par.
This dioxane derivative isn't just a line item in a catalog for us—it has solved real headaches for synthetic chemists who needed a stable yet versatile protected aldehyde. One long-standing client, developing a novel nucleoside, chose our compound after losing days to degradation from cheaper, unprotected alternatives. They reported handling less than a tenth of the byproduct output and nearly double the recovery rate during deprotection.
Other buyers, often working in early-stage drug discovery, choose this molecular scaffold when seeking chiral, protected aldehydes for coupling reactions. The 4R,6S configuration, painstakingly checked before every batch, shows up reliably in coupling outcomes; when we briefly tried shortcuts early on—skipping one chiral recrystallization—downstream yields dropped. This lived experience taught us not to cut corners when it comes to stereochemistry.
Each new intermediate brings unique challenges. In the case of tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate, scale-up required new thinking about solvent management. Smaller batches tolerated a range of water traces, but double-digit kilo runs sharpened issues around ring opening and incomplete acetal formation. We responded by introducing in-line Karl Fischer checks and daily instrument calibration routines—an investment in quality, not just regulatory box-ticking.
Batch consistency keeps the entire pipeline running smoothly for users. During one transition from pilot to regular manufacture, we learned that incremental changes—swapping in a new crystallizer, or shifting a drying temperature by a few degrees—could throw off stereochemical ratios or purity. Backtracking and troubleshooting helped us spot the critical points, and now every batch follows a process map built from those lessons.
Plenty of masked aldehydes crowd the commercial landscape, but this dioxane ester carves its niche where robust protection meets flexibility in unmasking. We've handled customers switching away from ethyl and methyl esters, frustrated by sluggish deprotection or excess transesterification. Substituting the tert-butyl group immediately lifted reaction rates and trimmed wastage. The dimethyl dioxane motif, resistant to nucleophile attack, gives peace of mind during harsher transformations—ours has survived conditions that reduce simple esters or acyclic aldehydes to gummy mixtures.
Our factory’s direct, everyday access to process feedback sets us apart from resellers—no mystery delays waiting for the “real” producer’s insights or root cause analysis. When we catch an outlier in analytical data, we rerun the process, then document what caused the deviation, and share this with users. This feedback loop, rarely visible in broker transactions, closes gaps quickly. Researchers don’t sit wondering about batch-to-batch reliability; they talk directly to the chemists who made their material.
Sealed samples held at controlled temperatures for extended periods continue to show robust stability. We store reference samples under ambient, refrigerated, and stress-tested (light and humidity) conditions. Across dozens of lots, loss in purity rarely crosses 1% over twelve months when samples stay cool and dry. We see the real threats come from repeated vial openings, especially when the compound hits warm, wet lab air. For this reason, we package in air- and moisture-tight containers, and coach our customers to follow the same care upon opening.
This constant vigilance comes not from abstract documents, but hard experience. On two occasions early in production, we traced small decreases in formyl peak by NMR not to internal impurity, but to rough storage in clients’ labs. We now pre-label bulk shipments for once-opened shelf life, and provide direct guidance on handling to reduce such problems. This shared responsibility keeps customers’ work on track and preserves material value.
Regulatory compliance begins with deep transparency. Each lot comes with a full, independently checked COA, but the trust extends beyond paperwork. Our internal lab regularly runs stability and impurity profiling as part of post-release audits. If a client or auditor flags a new analytical concern—from HPLC spikes to IR band overlaps—we don’t shrug or pass blame; our technical staff digs directly into the issue, sometimes offering improved purification in response.
We have found that meeting modern E-E-A-T standards—proven experience, authority, and transparent, evidence-driven processes—satisfies not just regulatory partners but also the companies relying on us at the bench. In borderline cases where another supplier’s batch fell short, users told us that our willingness to share full synthetic and analytical data made the difference in getting their own documentation past review.
In pharma and advanced chemical production, the cost of failed reactions isn’t just measured in lost material. Delays mean missed project milestones and financial ripple effects. Tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate’s stable, consistent performance helps customers avoid last-minute scrambles for alternatives or troubleshooting batch-dependent failures.
We have walked many of these projects hand-in-hand with technical teams. Early biopharma startups, for example, faced repeated setbacks due to poor reactivity from alternative masked aldehydes. After sharing our rigorous analytical reports and discussing real trial data, these customers successfully switched routes—often for multiple campaigns. The reduction in off-cycles and manual reprocessing is hard to quantify, but the feedback comes in project continuation and renewed PO’s.
We take chemical safety as seriously as product purity. Tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate, compared to more volatile small-molecule aldehydes, keeps its hazards contained under proper storage. With its bulk held in solid form, off-gassing or solvent evaporation rarely troubles our operators. Spill incidents nearly disappeared after revised procedures focused on tighter drum closures and quick containment for runaway reactions.
Documentation and training for lab use draw not just on publicly available data, but also feedback from seasoned chemists and EHS officers using our product at scale. Our guidance reflects experience managing kilo-scale containers, not just analytical vials; users repeatedly mention the practical, actionable details we supply over generic MSDS recommendations. For example, real-life storage life under different climates, how to prevent transfer losses, and what common solvent exposures to watch out for.
Environmental stewardship isn’t a slogan for us. Facing solvent-heavy operations and increasing regulatory scrutiny, we have taken major steps to limit waste streams and improve emissions handling for every batch. Multi-cycle solvent recovery, frequent equipment wash-down, and careful waste sorting form the bedrock of our day-to-day practices.
We took the initiative to rethink our filtration and recrystallization steps, phasing out certain hazardous auxiliaries where possible. Regular audits push us to find safer substitutes or more efficient purification options as new technology and feedback become available. For instance, the shift from older halogenated solvents to greener alternatives in product isolation cut both costs and environmental risk for us and, by extension, for downstream users achieving their own compliance goals.
Continuous feedback from the front lines—synthetic programs, pilot lines, and quality labs—shapes our process. We pay attention when a customer reports extended work-up times, suspect impurities, or handling issues. Such field reports led us to tweak both drying cycles and packaging over time, both reducing clumping and shortening thaw times for large shipments. Change isn’t a distant corporate goal, but part of our collaboration with the people using the material daily.
Occasionally a reverse inquiry arises—can we modify the ester group, or shift one ring substituent, to meet a niche application? Each request becomes an opportunity for targeted improvement, provided it fits with existing production lines. Our R&D and scale-up people meet weekly to trade updates on such projects, stay alert for needed adjustments, and report back to every client reaching out.
Direct experience sets apart tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate from more generic masked aldehydes or esters. Our hands-on producers see the improved handling every day—no overloaded columns, less off-odors than with lower-weight analogs, and fewer disposal headaches with inert byproducts.
Clients tell us that using this specific ring system skips extra steps in synthesis, avoids harsh hydrolysis conditions, and delivers chiral control lacking in low-cost substitutes. Many of our partners report lower overall costs once they factor in reduced rework and higher selectivity, compared to simply buying the cheapest catalog option. Consistency batch-to-batch and fast response to technical questions round out its role as a tool for advanced applications rather than a mere commodity.
We treat each lot as a learning experience—improving analytical sharpness, packing integrity, and sustainability. Prompt action on feedback opens opportunities to test new packaging for bulk orders, offer more frequent release data, or adapt specifications for clients’ challenging new applications. We remain committed to sharing not just the product, but what we learn about its behavior and performance, because we built our reputation on real results, not faceless transactions.
Those seeking smooth, scalable, and trustworthy advanced intermediates find in tert-butyl 2-((4R,6S)-6-formyl-2,2-dimethyl-1,3-dioxan-4-yl)acetate not just a chemical, but an ongoing partnership built around accountability, transparency, and technical engagement. We continue shaping both our product and our service in response to the needs of our customers, the lessons shared from their laboratories, and the disciplines of our manufacturing floor.